Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2
Elecsys IGRA SARS-CoV-2 test supports the better understanding of immune response to SARS-CoV-2 infection or vaccination The test detects T-cell response, which may play an important role in determining if immune protection has been achieved The new diagnostic test may provide clinical care guidance, particularly for immunocompromised and high-risk patient groups Basel, 15 August 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today …